Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallak, H.
Right arrow Articles by Rubin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallak, H.
Right arrow Articles by Rubin, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 4, 2255-2258, January 28, 2000

ACCELERATED PUBLICATION
Association of Heterotrimeric Gi with the Insulin-like Growth Factor-I Receptor
RELEASE OF Gbeta gamma SUBUNITS UPON RECEPTOR ACTIVATION*

Hazem Hallak, Andrea E. M. Seiler, Jaime S. Green, Brian N. Ross, and Raphael RubinDagger

From the Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Philadelphia, Pennsylvania 19107

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The insulin-like growth factor-I receptor (IGF-IR) is a key regulator of cell proliferation and survival. Activation of the IGF-IR induces tyrosine autophosphorylation and the binding of a series of adaptor molecules, thereby leading to the activation of MAPK. It has been demonstrated that pertussis toxin, which inactivates the Gi class of GTP-binding proteins, inhibits IGF-I-mediated activation of MAPK, and a specific role for Gbeta gamma subunits in IGF-I signaling was shown. In the present study, we have investigated the role of heterotrimeric Gi in IGF-IR signaling in neuronal cells. Pertussis toxin inhibited IGF-I-induced activation of MAPK in rat cerebellar granule neurons and NG-108 neuronal cells. Galpha i and Gbeta subunits were associated with IGF-IR immunoprecipitates. Similarly, in IGF-IR-null mouse embryo fibroblasts transfected with the human IGF-IR, Gi was complexed with the IGF-IR. Galpha s was not associated with the IGF-IR in any cell type. IGF-I induced the release of the Gbeta subunits from the IGF-IR but had no effect on the association of Galpha i. These results demonstrate an association of heterotrimeric Gi with the IGF-IR and identify a discrete pool of Gbeta gamma subunits available for downstream signaling following stimulation with IGF-I.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Many receptors are coupled to heterotrimeric GTP-binding proteins (G-proteins). Prototypic G-protein coupled receptors (GPCRs)1 contain a seven-membrane spanning region (1). Activated GPCRs bind to G-proteins and induce the release of Gbeta gamma subunits from Galpha subunits, which allows for the exchange of GDP for GTP on the Galpha subunit. Activated Gi subunits and Gbeta gamma heterodimers interact with numerous signaling effectors, including adenylyl cyclase, ion channels, protein kinases, and phospholipases (2-4).

In addition to their role in fully differentiated cells, GPCRs have been linked to mitogenesis and development (5-8). A specific role for Gi in the induction of mitogenesis has been highlighted by the use of pertussis toxin, which inactivates Gi by ADP-ribosylation of the Galpha subunit. However, Galpha subunits from several classes of G-proteins are not strongly mitogenic. Rather Gbeta gamma heterodimer subunits activate a series of nonreceptor tyrosine kinases, which in turn activates p21ras and extracellular signal-regulated kinases (or MAPK). Thus, Gbeta gamma subunits serve to bridge intracellular signaling of classical GPCRs and mitogenic tyrosine kinase receptors (RTKs).

Gi also appears to be involved in the mitogenic actions of RTKs. Pertussis toxin variably inhibits the metabolic actions of insulin, both in vitro and in vivo (9-16), and the insulin receptor may associate with Gi (17-19). Importantly, mice with targeted knockout of Gi have defects in insulin signaling (20). EGF-dependent signaling is also impaired by pertussis toxin in rat hepatocytes (21-23) and other cells (24-27).

The insulin-like growth factor-I receptor (IGF-IR), which has strong homology to the insulin receptor, exists as an alpha 2-beta 2-heterodimer and contains a cytoplasmic tyrosine kinase domain (28, 29). Upon activation by its ligands IGF-I and IGF-II, the IGF-IR undergoes tyrosine autophosphorylation, after which it phosphorylates key signaling molecules and leads to the sequential activation of ras, raf, and MAPK. The role of Gi in signaling by the IGF-IR is controversial. In fibroblasts, pertussis toxin inhibits the IGF-I-induced opening of a calcium-permeable cation channel (30) and the activation of MAPK (31). In the latter study, Luttrell et al. (31) demonstrated that MAPK activation by IGF-I was also inhibited by Gbeta gamma subunit binding proteins. Inhibitory effects of pertussis toxin have been observed for other IGF-I-dependent cellular effects (32-35) although not in all cases (36-39).

Because IGF-I exerts profound proliferative and survival effects on many cell types, including neuronal cells, we have investigated the role of Gi in IGF-I signaling in neuronal cells. We report the specific association of Gi with the IGF-IR and inhibition of MAPK activation by pertussis toxin. Importantly, IGF-I stimulation induces the release of Gbeta gamma subunits from the IGF-IR. The findings offer a model wherein Gi heterotrimers are constitutively associated with the IGF-IR and identify a discrete pool of Gbeta gamma subunits available for IGF-IR signaling.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Antibodies against Galpha i, Galpha s, Gbeta , IGF-IR beta  domain, and anti-phosphotyrosine (py99) were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-MAPK and anti-phospho-MAPK (E10) antibodies, horseradish peroxidase-conjugated goat anti-rabbit IgG, and horse anti-mouse IgG antibodies and signal-enhanced chemiluminescence reagents were obtained from New England Biolabs (Beverly, MA). Pertussis toxin was purchased from Calbiochem (La Jolla, CA). Human recombinant IGF-I was obtained from Bachem Bioscience, Inc., (King of Prussia, PA). All other chemical and biochemicals were of the highest purity commercially available.

Cell Lines and Culture Conditions-- Balb/c3T3 cells were obtained from American Type Culture Collection (Manassas, VA). Mouse embryo fibroblasts with targeted knockout of the IGF-IR (R- cells) and R- cells that express human IGF-IR (R+) cells were a gift from Dr. R. Baserga (Kimmel Cancer Center, Thomas Jefferson University). The generation and characterization of R- and R+ cells have been described elsewhere (40, 41). Fibroblasts were passaged in Dulbecco's modified Eagle's medium supplemented with 10% normal calf serum and 2 mM glutamine. NG-108 neuroblastoma cells, a gift from Dr. I. Diamond, University of California, were cultured in Dulbecco's modified Eagle's medium containing 6% (v/v/) fetal calf serum and supplemented with 1 µM aminopterin, 100 µM hypoxanthine, and 16 µM thymidine. Fibroblasts and NG-108 cells were cultured in serum-free medium for 18 h prior to addition of IGF-I. Where indicated, cells were treated with pertussis toxin for 4 h prior to the addition of IGF-I.

Rat cerebellar granule neurons were prepared from 7-day-old rat pups as reported previously (42, 43). Briefly, cerebella were obtained from postnatal day 7 Harlan Sprague-Dawley rat pups, cross-chopped (400 × 400 µM), and then treated with 0.025% trypsin-EDTA (including 0.01% DNase I) for 15 min, 37 °C. Cells were triturated and plated at a density of 1 × 106/cm2 on poly-D-lysine-coated plates in Basal Medium Eagle (BME) containing 10% fetal bovine serum, 25 mM KCl, 100 units/ml penicillin, 100 µg/ml streptomycin, and 0.25 µg/ml amphotericin B. 10 µM cytosine arabinoside was added after 24 h to inhibit nonneuronal replication. Cerebellar neurons were used after 7 days in vitro. For treatment with IGF-I, cells were washed twice and cultured for 2 h in BME with 5 mM KCl.

Immunoprecipitations and Western Blot Analysis-- Cells were lysed in ice-cold Triton lysis buffer (50 mM HEPES (pH 7.5), 150 mM NaCl, 1.5 mM MgCl2, 1 mM EGTA, 0.5 mM EDTA, 10% glycerol, 1% Triton X-100, 100 mM NaF, 2 mM Na3VO4, 10 mM sodium PPI, 10 mM phenylmethylsulfonyl fluoride, 500 µM AEBSF (Sigma), 150 nM aprotinin, 1 µM E-64 (Sigma), and 1 µM leupeptin). The lysates were centrifuged at 14,000 × g for 10 min at 4 °C, and the supernatants were collected. Protein concentrations were determined by a colorimetric assay (44). Cell lysates containing 30 µg of protein were electrophoresed in 11% denaturing polyacrylamide gels. For immunoprecipitations, supernatants were diluted with 1 volume of HNTG (20 mM HEPES (pH 7.5), 150 mM NaCl, 0.1% Triton X-100, 10 mM NaF and 2 mM Na3VO4). Equal amounts of protein (250 µg) from each sample were immunoprecipitated using 0.4 µg/ml of antibody to either IGF-IR or G-protein subunits and were captured using protein A-agarose beads. Immunoprecipitates were subjected to SDS-PAGE, transferred to Immobilon-P membranes and visualized by Western blotting. For Western blot analysis, the proteins were transferred to Immobilon-P membranes, blocked with 3% bovine serum albumin and probed with antibodies (1:2000 for all antibodies except 1:1000 for anti-MAPK antibodies), followed by secondary horseradish peroxidase-conjugated goat anti-rabbit IgG or horse anti-mouse IgG antibodies. Membranes were visualized by enhanced chemiluminescence (Amersham Pharmacia Biotech). The figures are scanned images and are representative of 3-5 experiments.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The role of Gi in the activation of p42/p44 MAPK by IGF-I was investigated in Balb/c 3T3 cells, rat cerebellar granule neurons, and NG-108 neuronal cells (Fig. 1). Basal MAPK phosphorylation was reduced by pertussis toxin in Balb/c 3T3 and NG-108 cells but not in cerebellar granule neurons. In agreement with a previous report (31), pertussis toxin markedly inhibited IGF-I-induced MAPK phosphorylation in all cell types. Total MAPK content was unchanged under all conditions. Pertussis treatment had no effect on cell viability. Pertussis toxin inactivates both Gi and Go, but 3T3 cells lack Go. The results indicate that Gi is at least partially required for MAPK activation by IGF-I.


View larger version (64K):
[in this window]
[in a new window]
 
Fig. 1.   Pertussis toxin inhibits activation of MAPK by IGF-I. Cerebellar granule neurons, NG-108 cells, or Balb/c 3T3 cells were treated with IGF-I (25 ng/ml) for 10 min in the presence or absence of pertussis toxin (200 ng/ml). Phospho-MAPK and MAPK levels were determined by Western blotting as described under "Experimental Procedures."

Having established a requirement for Gi in IGF-I-induced neuronal MAPK activation, we next examined the relationship between Galpha i and the IGF-IR. IGF-IR was immunoprecipitated under nondenaturing conditions and probed for Galpha i content by Western blot analysis with anti-Galpha i antibody. Fig. 2 illustrates that Galpha i is associated with the IGFR-I in both cerebellar granule cells and NG-108 cells. The IGF-IR and Galpha i were similarly complexed in Balb/c 3T3 cells (data not shown). Galpha s subunits were not detected in IGF-IR immunoprecipitates from any cell type despite copious expression in total cell lysates (not shown). The IGF-IR/Galpha i interaction was completely disrupted when the IGF-IR was immunoprecipitated under denaturing conditions (not shown). IGF-I had no effect on the association of Galpha i with the IGF-IR. The IGF-IR was active under these experimental conditions, as manifest by IGF-I-induced tyrosine autophosphorylation of the beta  domain of the IGF-IR in both cell types (Fig. 2, bottom panel).


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 2.   Galpha i subunit associates with the IGF-IR. The IGF-IR was immunoprecipitated from cerebellar granule neurons and NG-108 cells either before or after a 10-min treatment with IGF-I (25 ng/ml). Immunoprecipitates were probed for Galpha i (top), IGF-IR (middle), or phosphotyrosine content (bottom) by Western blotting, as described under "Experimental Procedures."

The anti-IGF-IR antibody did not cross-react with Galpha i. Fig. 3 demonstrates that Galpha i subunits were not identified using anti-IGF-IR antibodies in mouse embryo fibroblasts with targeted knockout of the IGF-IR (R- cells). Both proteins were immunoprecipitated by anti-IGF-IR antibody upon restoration of IGF-IR expression (R+ cells)


View larger version (40K):
[in this window]
[in a new window]
 
Fig. 3.   Anti-IGF-IR antibody requires IGF-IR to immunoprecipitate Galpha i. Lysates or anti-IGF-IR immunoprecipitates were obtained from R- (R-) or R+ (R+) cells and probed for Galpha i (top panels) and IGF-IR content (bottom panels) by Western blotting.

A requirement for Gbeta gamma subunit release in IGF-IR-induced MAPK activation was suggested by the studies of Luttrell et al. (31). In conjunction with the observation that Galpha i does not dissociate from the IGF-IR in response to IGF-I, we conjectured that IGF-I induces Gbeta gamma subunit release from the IGF-IR. Fig. 4 demonstrates that Gbeta subunit coimmunoprecipitates with the IGF-IR in both cerebellar granule neurons and NG-108 cells. The amount of Gbeta subunit associated with the IGF-IR decreased dramatically in response to IGF-I. Gbeta subunit expression within total cell lysates was identical under all conditions. Fig. 4 also demonstrates that pertussis toxin prevented the release of Gbeta subunit from the IGF-IR but had no effect on the expression of IGF-IR or Gbeta subunit. We conclude that heterotrimeric Gi is constitutively associated with IGF-IR and responds to IGF-I by release of free Gbeta gamma subunits.


View larger version (58K):
[in this window]
[in a new window]
 
Fig. 4.   IGF-I induces the release of Gbeta subunit from the IGF-IR complex. IGF-IR immunoprecipitates were obtained from cerebellar granule neurons and NG-108 cells either before or after a 10-min treatment with IGF-I (25 ng/ml), in the presence or absence of pertussis toxin. Gbeta subunit content within IGF-IR immunoprecipitates or total lysates was determined by Western blotting. Gbeta content within total lysates is also shown.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The use of pertussis toxin and beta gamma subunit binding proteins has provided indirect evidence for an additional role of Gi in the activation of MAPK by IGF-I (31). In the current study, we extended these findings to neuronal cell types and now provide direct evidence for the constitutive association of heterotrimeric Gi with the IGF-IR complex. Both Galpha i and Gbeta subunits co-immunoprecipitate with IGF-IR in cerebellar neurons and NG-108 cells. Importantly, IGF-I induces the release of Gbeta subunits from the IGF-IR complex, whereas the association of Galpha i with the IGF-IR is unaffected. The current data do not allow us to determine whether Galpha i binds directly to the IGF-IR or to another protein in the IGF-IR complex. Gbeta gamma subunits exhibit a pleckstrin homology domain which mediates binding to several molecules that are part of the IGF-IR signaling complex including IRS-1 and PI 3-kinase (3). However, these interactions are unlikely to play a role in binding of Gbeta gamma subunits to the IGF-IR because IRS-1 and PI 3-kinase are not bound to the IGF-IR in its unactivated state.

RTKs for insulin, IGF-I and EGF, among others, contain SH2 binding domains which anchor adaptor proteins such as IRS-1 and Shc (28, 29). Phosphorylation of these intermediaries leads to the activation of p21ras, MAPK, and transcriptional activation. Both IRS-1 and Shc can independently lead to MAPK activation, although studies in some cell types have suggested that Shc may ultimately be more important for mitogenesis (45, 46). The IGF-IR also activates PI 3-kinase, which has diverse functions, including an anti-apoptotic role mediated by its activation of Akt (47-49). However, the relative contribution of these diverse signaling pathways to functional effects must be studied individually. There is also ample experimental evidence to support a role for the IGF-IR in the maintenance of the transformed phenotype. Notably, R- cells are resistant to transformation in response to several oncogenic influences (50). Transformation is restored upon expression of the IGF-IR. In contrast, Leroith and co-workers have recently demonstrated that a constitutively active mutant of Galpha 13 can transform R- cells (51).

The role of Gi in IGF-I signaling likely varies among different cell types. Pertussis toxin variably inhibits biological actions of IGF-I. In 3T3 cells (30) and chondrocytes (32), pertussis toxin inhibits IGF-I-induced mobilization of intracellular calcium. Anti-Galpha i antibodies inhibit the opening of a calcium-permeable cation channel in response to IGF-I (30). Pertussis toxin also inhibits the activation of human neutrophil phagocytosis (35) and blocks IGF-I induced proliferation of myoblasts (33). By contrast, pertussis toxin failed to inhibit several IGF-I-dependent phenomena including GTP[S] binding to rat kidney epithelial cell membranes (36), DNA synthesis in MG-63 osteosarcoma cells (38), and IGF-I-induced human melanoma cell motility (39). We have also noted that pertussis toxin has no effect on the ability of IGF-I to protect cerebellar granule cells from apoptosis induced by removal of growth factors and low extracellular potassium (43, 52).2 Thus, as is the case for other signaling mediators of the IGF-IR, the specific functional role of Gbeta gamma subunits in IGF-I signaling is likely dependent upon cell context.

Gi may also associate with the insulin receptor. Galpha i2 and Gbeta (but not Galpha i1 or Galpha i3) were identified in purified insulin receptor preparations (14). In a recent study, Sanchez et al. (19) reported that activation of the insulin receptor recruits Galpha i to this receptor, in a manner similar to classical GPCRs. However, this differs from our finding that Galpha i constitutively associates with the IGF-IR. Pertussis toxin inhibits metabolic and mitogenic actions of insulin in a variety of cell culture models (9-16), and insulin enhances GTP binding to membranes (16, 18). In a recent study of rat hepatoma cell membranes (19), antibodies targeted against Galpha i but not Galpha o, prevented insulin-stimulated GTP binding. Similarly, anti-Galpha i antibodies blocks insulin-induced NADPH-dependent generation of hydrogen peroxide in human adipocyte membranes (14).

The mechanism by which the IGF-IR induces Gbeta gamma subunit release is unclear. Direct tyrosine phosphorylation of Galpha i by the insulin receptor was suggested in studies of phospholipid vesicles co-inserted with Galpha i (17). However, other data are inconsistent with the notion that Galpha i is phosphorylated by the insulin receptor (53-56). Thus, a pathway other than tyrosine kinase activation may account for Gbeta gamma release, perhaps a configurational change induced by IGF-I. Our preliminary studies are in agreement with this view. Although we can detect tyrosine phosphate residues within Galpha i by Western blotting, IGF-I has no effect on the tyrosine phosphorylation state of the Galpha i subunit protein.

In conclusion, this study demonstrates the constitutive association of Gi with the IGF-IR, and provides a mechanism for release of an IGF-I-sensitive pool of Gbeta gamma subunits. In cerebellar granule cells and NG-108 cells specifically, Gbeta gamma subunit release is required for MAPK activation. The findings highlight the potential role of Gbeta gamma subunits in the regulation of neuronal MAPK activity, which is a key element in neuronal development and regeneration.

    ACKNOWLEDGEMENT

We thank Dr. Kevin Williams for helpful discussions.

    FOOTNOTES

* This research was supported by National Institutes of Health Grants AA09976, AA07186, and AHA9730028N.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Dept. of Pathology, Anatomy and Cell Biology, 1020 Locust St., Rm. 233, Alumni Hall, Philadelphia, PA 19107. Tel.: (215)503-0417; Fax: (215)955-8703; E-mail: raphael.rubin@mail.tju.edu.

2 H. Hallak, and R. Rubin, unpublished data.

    ABBREVIATIONS

The abbreviations used are: GPCR, G-protein coupled receptor; MAPK, mitogen-activated protein kinase; RTK, tyrosine kinase receptor; IGF-IR, insulin-like growth factor-I receptor; PI 3-kinase, phosphatidylinositol 3-kinase; IRS-1, insulin receptor substrate-1.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Ji, T. H., Grossmann, M., and Ji, I. (1998) J. Biol. Chem. 273, 17299-17302[Free Full Text]
2. Gilman, A. G. (1987) Annu. Rev. Biochem. 56, 615-649[CrossRef][Medline] [Order article via Infotrieve]
3. Clapham, D. E., and Neer, E. J. (1997) Annu. Rev. Pharmacol. Toxicol. 37, 167-203[CrossRef][Medline] [Order article via Infotrieve]
4. Hamm, H. E. (1998) J. Biol. Chem. 273, 669-672[Free Full Text]
5. van Biesen, T., Luttrell, L. M., Hawes, B. E., and Lefkowitz, R. J. (1996) Endocr. Rev. 17, 698-714[Abstract/Free Full Text]
6. Gutkind, J. S. (1998) J. Biol. Chem. 273, 1839-1842[Free Full Text]
7. Rozengurt, E. (1998) J. Cell. Physiol. 177, 507-517[CrossRef][Medline] [Order article via Infotrieve]
8. Lopez-Ilasaca, M. (1998) Biochem. Pharmacol. 56, 269-277[CrossRef][Medline] [Order article via Infotrieve]
9. Goren, H. J., Northup, J. K., and Hollenberg, M. D. (1985) Can. J. Physiol. Pharmacol. 63, 1017-1022[Medline] [Order article via Infotrieve]
10. Heyworth, C. M., Grey, A. M., Wilson, S. R., Hanski, E., and Houslay, M. D. (1986) Biochem. J. 235, 145-149[Medline] [Order article via Infotrieve]
11. Vila, M. C., Milligan, G., Standaert, M. L., and Farese, R. V. (1990) Biochemistry 29, 8735-8740[CrossRef][Medline] [Order article via Infotrieve]
12. Curto, M., Piccinini, M., Rabbone, I., Mioletti, S., Mostert, M., Bruno, R., and Rinaudo, M. T. (1997) Int. J. Biochem. Cell Biol. 29, 1207-1217[CrossRef][Medline] [Order article via Infotrieve]
13. Nie, L., Kanzaki, M., Shibata, H., and Kojima, I. (1998) Endocrinology 139, 179-188[Abstract/Free Full Text]
14. Krieger-Brauer, H. I., Medda, P. K., and Kather, H. (1997) J. Biol. Chem. 272, 10135-10143[Abstract/Free Full Text]
15. Butler, A. P., Martinez, L. A., and Montgomery, R. L. (1996) Cell Signal. 8, 475-480[CrossRef][Medline] [Order article via Infotrieve]
16. Kellerer, M., Obermaier-Kusser, B., Profrock, A., Schleicher, E., Seffer, E., Mushack, J., Ermel, B., and Haring, H. U. (1991) Biochem. J. 276, 103-108
17. Krupinski, J., Rajaram, R., Lakonishok, M., Benovic, J. L., and Cerione, R. A. (1988) J. Biol. Chem. 263, 12333-12341[Abstract/Free Full Text]
18. Okamoto, T., Okamoto, T., Murayama, Y., Hayashi, Y., Ogata, E., and Nishimoto, I. (1994) FEBS Lett. 340, 292-293[CrossRef][Medline] [Order article via Infotrieve]
19. Sanchez-Margalet, V., Gonzalez-Yanes, C., Santos-Alvarez, J., and Najib, S. (1999) Cell Mol. Life Sci. 55, 142-147[CrossRef][Medline] [Order article via Infotrieve]
20. Moxham, C. M., and Malbon, C. C. (1996) Nature 379, 840-844[CrossRef][Medline] [Order article via Infotrieve]
21. Yang, L. J., Baffy, G., Rhee, S. G., Manning, D., Hansen, C. A., and Williamson, J. R. (1991) J. Biol. Chem. 266, 22451-22458[Abstract/Free Full Text]
22. Yang, L., Camoratto, A. M., Baffy, G., Raj, S., Manning, D. R., and Williamson, J. R. (1993) J. Biol. Chem. 268, 3739-3746[Abstract/Free Full Text]
23. Liang, M. N., and Garrison, J. C. (1991) J. Biol. Chem. 266, 13342-13349[Abstract/Free Full Text]
24. Ramirez, I., Tebar, F., Grau, M., and Soley, M. (1995) Cell Signal. 7, 303-311[CrossRef][Medline] [Order article via Infotrieve]
25. Church, J. G., and Buick, R. N. (1988) J. Biol. Chem. 263, 4242-4246[Abstract/Free Full Text]
26. Piiper, A., Stryjek-Kaminska, D., and Zeuzem, S. (1997) Am. J. Physiol 272, G1276-G1284[Abstract/Free Full Text]
27. Tebar, F., Ramirez, I., and Soley, M. (1993) J. Biol. Chem. 268, 17199-17204[Abstract/Free Full Text]
28. Rubin, R., and Baserga, R. (1995) Lab. Invest. 73, 311-331[Medline] [Order article via Infotrieve]
29. LeRoith, D., Werner, H., Beitner-Johnson, D., and Roberts, C. T., Jr. (1995) Endocr. Rev. 16, 143-163[Abstract/Free Full Text]
30. Kanzaki, M., Nie, L., Shibata, H., and Kojima, I. (1997) J. Biol. Chem. 272, 4964-4969[Abstract/Free Full Text]
31. Luttrell, L. M., van Biesen, T., Hawes, B. E., Koch, W. J., Touhara, K., and Lefkowitz, R. J. (1995) J. Biol. Chem. 270, 16495-16498[Abstract/Free Full Text]
32. Poiraudeau, S., Lieberherr, M., Kergosie, N., and Corvol, M. T. (1997) J. Cell. Biochem. 64, 414-422[CrossRef][Medline] [Order article via Infotrieve]
33. Sarbassov, D. D., Jones, L. G., and Peterson, C. A. (1997) Mol. Endocrinol. 11, 2038-2047[Abstract/Free Full Text]
34. Uehara, T., Tokumitsu, Y., and Nomura, Y. (1999) Eur. J. Biochem. 259, 801-808[Medline] [Order article via Infotrieve]
35. Jin, G. F., Guo, Y. S., Ball, C., and Houston, C. W. (1993) Regul. Pept. 49, 125-131[CrossRef][Medline] [Order article via Infotrieve]
36. Siebler, T., Kiess, W., Linder, B., Kessler, U., Schwarz, H. P., and Nissley, S. P. (1996) Regul. Pept. 62, 65-71[CrossRef][Medline] [Order article via Infotrieve]
37. Langlois, D., Hinsch, K. D., Saez, J. M., and Begeot, M. (1990) Endocrinology 126, 1867-1872[Abstract/Free Full Text]
38. Linder, B., Harris, S., Eisen, A., and Nissley, P. (1994) Mol. Cell. Endocrinol. 105, 111-118[CrossRef][Medline] [Order article via Infotrieve]
39. Stracke, M. L., Kohn, E. C., Aznavoorian, S. A., Wilson, L. L., Salomon, D., Krutzsch, H. C., Liotta, L. A., and Schiffmann, E. (1988) Biochem. Biophys. Res. Commun. 153, 1076-1083[CrossRef][Medline] [Order article via Infotrieve]
40. Sell, C., Rubini, M., Rubin, R., Liu, J. P., Efstratiadis, A., and Baserga, R. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 11217-11221[Abstract/Free Full Text]
41. Sell, C., Dumenil, G., Deveaud, C., Miura, M., Coppola, D., DeAngelis, T., Rubin, R., Efstratiadis, A., and Baserga, R. (1994) Mol. Cell. Biol. 14, 3604-3612[Abstract/Free Full Text]
42. Zhang, F. X., Rubin, R., and Rooney, T. A. (1998) J. Neurochem. 71, 196-204[Medline] [Order article via Infotrieve]
43. Zhang, F. X., Rubin, R., and Rooney, T. A. (1998) J. Biol. Chem. 273, 26596-26602[Abstract/Free Full Text]
44. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254[CrossRef][Medline] [Order article via Infotrieve]
45. Yamauchi, K., and Pessin, J. E. (1994) Mol. Cell. Biol. 14, 4427-4434[Abstract/Free Full Text]
46. Yamauchi, K., and Pessin, J. E. (1994) J. Biol. Chem. 269, 31107-31114[Abstract/Free Full Text]
47. Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. (1997) Science 275, 661-665[Abstract/Free Full Text]
48. Kulik, G., Klippel, A., and Weber, M. J. (1997) Mol. Cell. Biol. 17, 1595-1606[Abstract]
49. del Peso, L., Gonzalez-Garcia, M., Page, C., Herrera, R., and Nunez, G. (1997) Science 278, 687-689[Abstract/Free Full Text]
50. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. (1997) Biochim. Biophys. Acta 1332, F105-F126[Medline] [Order article via Infotrieve]
51. Liu, J. L., Blakesley, V. A., Gutkind, J. S., and LeRoith, D. (1997) J. Biol. Chem. 272, 29438-29441[Abstract/Free Full Text]
52. D'Mello, S. R., Galli, C., Ciotti, T., and Calissano, P. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 10989-10993[Abstract/Free Full Text]
53. Luttrell, L., Kilgour, E., Larner, J., and Romero, G. (1990) J. Biol. Chem. 265, 16873-16879[Abstract/Free Full Text]
54. Gawler, D., and Houslay, M. D. (1987) FEBS Lett. 216, 94-98[CrossRef][Medline] [Order article via Infotrieve]
55. Pyne, N. J., Heyworth, C. M., Balfour, N. W., and Houslay, M. D. (1989) Biochem. Biophys. Res. Commun. 165, 251-256[CrossRef][Medline] [Order article via Infotrieve]
56. Rothenberg, P. L., and Kahn, C. R. (1988) J. Biol. Chem. 263, 15546-15552[Abstract/Free Full Text]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
R. X.-D. Song, Z. Zhang, Y. Chen, Y. Bao, and R. J. Santen
Estrogen Signaling via a Linear Pathway Involving Insulin-Like Growth Factor I Receptor, Matrix Metalloproteinases, and Epidermal Growth Factor Receptor to Activate Mitogen-Activated Protein Kinase in MCF-7 Breast Cancer Cells
Endocrinology, August 1, 2007; 148(8): 4091 - 4101.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. M. El-Shewy, K. R. Johnson, M.-H. Lee, A. A. Jaffa, L. M. Obeid, and L. M. Luttrell
Insulin-like Growth Factors Mediate Heterotrimeric G Protein-dependent ERK1/2 Activation by Transactivating Sphingosine 1-Phosphate Receptors
J. Biol. Chem., October 20, 2006; 281(42): 31399 - 31407.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Akekawatchai, J. D. Holland, M. Kochetkova, J. C. Wallace, and S. R. McColl
Transactivation of CXCR4 by the Insulin-like Growth Factor-1 Receptor (IGF-1R) in Human MDA-MB-231 Breast Cancer Epithelial Cells
J. Biol. Chem., December 2, 2005; 280(48): 39701 - 39708.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. H. T. Wu and Y. H. Wong
Involvement of Gi/o Proteins in Nerve Growth Factor-Stimulated Phosphorylation and Degradation of Tuberin in PC-12 Cells and Cortical Neurons
Mol. Pharmacol., April 1, 2005; 67(4): 1195 - 1205.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
T. B. Patel
Single Transmembrane Spanning Heterotrimeric G Protein-Coupled Receptors and Their Signaling Cascades
Pharmacol. Rev., September 1, 2004; 56(3): 371 - 385.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Ibarra, M. Estrada, L. Carrasco, M. Chiong, J. L. Liberona, C. Cardenas, G. Diaz-Araya, E. Jaimovich, and S. Lavandero
Insulin-like Growth Factor-1 Induces an Inositol 1,4,5-Trisphosphate-dependent Increase in Nuclear and Cytosolic Calcium in Cultured Rat Cardiac Myocytes
J. Biol. Chem., February 27, 2004; 279(9): 7554 - 7565.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
A. W. Orr, C. E. Pedraza, M. A. Pallero, C. A. Elzie, S. Goicoechea, D. K. Strickland, and J. E. Murphy-Ullrich
Low density lipoprotein receptor-related protein is a calreticulin coreceptor that signals focal adhesion disassembly
J. Cell Biol., June 23, 2003; 161(6): 1179 - 1189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. F. Wan, B. S. Sambi, R. Tate, C. Waters, and N. J. Pyne
The Inhibitory gamma Subunit of the Type 6 Retinal cGMP Phosphodiesterase Functions to Link c-Src and G-protein-coupled Receptor Kinase 2 in a Signaling Unit That Regulates p42/p44 Mitogen-activated Protein Kinase by Epidermal Growth Factor
J. Biol. Chem., May 9, 2003; 278(20): 18658 - 18663.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang and X. J. Liu
A G Protein-coupled Receptor Kinase Induces Xenopus Oocyte Maturation
J. Biol. Chem., April 25, 2003; 278(18): 15809 - 15814.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Waters, B. Sambi, K.-C. Kong, D. Thompson, S. M. Pitson, S. Pyne, and N. J. Pyne
Sphingosine 1-Phosphate and Platelet-derived Growth Factor (PDGF) Act via PDGFbeta Receptor-Sphingosine 1-Phosphate Receptor Complexes in Airway Smooth Muscle Cells
J. Biol. Chem., February 14, 2003; 278(8): 6282 - 6290.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. A. Booth, C. Cummings, M. Tiberi, and X. J. Liu
GIPC Participates in G Protein Signaling Downstream of Insulin-like Growth Factor 1 Receptor
J. Biol. Chem., February 15, 2002; 277(8): 6719 - 6725.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Tao, C. C. Malbon, and H.-y. Wang
Galpha i2 Enhances Insulin Signaling via Suppression of Protein-tyrosine Phosphatase 1B
J. Biol. Chem., October 19, 2001; 276(43): 39705 - 39712.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Faivre, K. Regnauld, E. Bruyneel, Q.-D. Nguyen, M. Mareel, S. Emami, and C. Gespach
Suppression of Cellular Invasion by Activated G-Protein Subunits Galpha o, Galpha i1, Galpha i2, and Galpha i3 and Sequestration of Gbeta gamma
Mol. Pharmacol., August 1, 2001; 60(2): 363 - 372.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
C. M. Boney, H. Sekimoto, P. A. Gruppuso, and A. R. Frackelton Jr.
Src Family Tyrosine Kinases Participate in Insulin-like Growth Factor I Mitogenic Signaling in 3T3-L1 Cells
Cell Growth Differ., July 1, 2001; 12(7): 379 - 386.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. Rakhit, S. Pyne, and N. J. Pyne
Nerve Growth Factor Stimulation of p42/p44 Mitogen-Activated Protein Kinase in PC12 Cells: Role of Gi/o, G Protein-Coupled Receptor Kinase 2, beta -Arrestin I, and Endocytic Processing
Mol. Pharmacol., July 1, 2001; 60(1): 63 - 70.
[Abstract] [Full Text]


Home page
Mol. Pharmacol.Home page
S. Rakhit, S. Pyne, and N. J. Pyne
The Platelet-Derived Growth Factor Receptor Stimulation of p42/p44 Mitogen-Activated Protein Kinase in Airway Smooth Muscle Involves a G-Protein-Mediated Tyrosine Phosphorylation of Gab1
Mol. Pharmacol., August 1, 2000; 58(2): 413 - 420.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. I. Krieger-Brauer, P. Medda, and H. Kather
Basic Fibroblast Growth Factor Utilizes Both Types of Component Subunits of Gs for Dual Signaling in Human Adipocytes. STIMULATION OF ADENYLYL CYCLASE VIA Galpha s AND INHIBITION OF NADPH OXIDASE BY Gbeta gamma s
J. Biol. Chem., November 10, 2000; 275(46): 35920 - 35925.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. L. Roudabush, K. L. Pierce, S. Maudsley, K. D. Khan, and L. M. Luttrell
Transactivation of the EGF Receptor Mediates IGF-1-stimulated Shc Phosphorylation and ERK1/2 Activation in COS-7 Cells
J. Biol. Chem., July 14, 2000; 275(29): 22583 - 22589.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Guillard, S. Chretien, R. Jockers, S. Fichelson, P. Mayeux, and V. Duprez
Coupling of Heterotrimeric Gi Proteins to the Erythropoietin Receptor
J. Biol. Chem., January 12, 2001; 276(3): 2007 - 2014.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. F. Kuemmerle and K. S. Murthy
Coupling of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase to Gi2 in Human Intestinal Smooth Muscle. Gbeta gamma -DEPENDENT MITOGEN-ACTIVATED PROTEIN KINASE ACTIVATION AND GROWTH
J. Biol. Chem., March 2, 2001; 276(10): 7187 - 7194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Alderton, S. Rakhit, K. C. Kong, T. Palmer, B. Sambi, S. Pyne, and N. J. Pyne
Tethering of the Platelet-derived Growth Factor beta Receptor to G-protein-coupled Receptors. A NOVEL PLATFORM FOR INTEGRATIVE SIGNALING BY THESE RECEPTOR CLASSES IN MAMMALIAN CELLS
J. Biol. Chem., July 20, 2001; 276(30): 28578 - 28585.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. F. Wan, B. S. Sambi, M. Frame, R. Tate, and N. J. Pyne
The Inhibitory gamma Subunit of the Type 6 Retinal Cyclic Guanosine Monophosphate Phosphodiesterase Is a Novel Intermediate Regulating p42/p44 Mitogen-activated Protein Kinase Signaling in Human Embryonic Kidney 293 Cells
J. Biol. Chem., October 5, 2001; 276(41): 37802 - 37808.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hallak, H.
Right arrow Articles by Rubin, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hallak, H.
Right arrow Articles by Rubin, R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement